Remicade was firsted approved for use by patients with Rheumatoid Arthritis. There have been more and longer term Remicade studies in this group of patients. You might find it reassuring to read the report compiled from data presented at the American College of Rheumatology Scientific meeting in October 2008.
Risks and Adverse Events Associated With Biologic Agents for Rheumatoid Arthritis
Moderator Crohn's Disease Forum
CD, Ankylosing Spondylitis, lupus, small fiber peripheral neuropathy, avascular necrosis, peripheral artery disease, degenerative disc disease, and a host of other medical problems.